The crisis of AIDS was identified by GlaxoSmithKline, and its decisions affected thousands in Africa. There were no ready answers to the disaster, but everyone-- the media, nongovernmental organizations, governments, investors, and others--had an opinion. GSK had to decide the best way to address the disaster while keeping business viability in developing countries in the midst of all the pressures.
In addressing critics proactive, he was viewed as the de facto representative for the pharmaceutical sector in addressing these critical problems. The tone was established by these communications for its global operations and the company.
This is just an excerpt. This case is about GLOBAL BUSINESS
Related Case Solutions & Analyses:
SAS Real Estate: To Fire or Not to Fire?
Hewlett-Packard–Compaq: The Merger Decision
Juchheim: The Failthful Pursuit of Flavour, Culture and Family Values
Tower of Saviors or Toilet of Plagiarists? The Tale of a Mobile Game
Conseco Senior Health Insurance: A Strategic Problem of Reputation and Regulation
China and the Yuan-Dollar Exchange Rate
Innovative Culture: Values, Principles and Practices of Senior Executives in Highly Innovative Companies
AdMob (A)
Damien Hirst and the contemporary art market
The Fall of Banco Espirito Santo: Holy Spirit or Devil in Disguise?
